4.6 Article

Development and Validation of Nomograms to Predict Cancer-Specific Survival and Overall Survival in Elderly Patients With Prostate Cancer: A Population-Based Study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Review Urology & Nephrology

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer

Philip Cornford et al.

Summary: The 2020 EAU-EANM-ESTRO-ESUR-SIOG guidelines provide evidence-based guidance on the treatment of relapsing, metastatic, and castration-resistant prostate cancer. These guidelines are continuously updated to reflect the latest research findings in the field.

EUROPEAN UROLOGY (2021)

Review Urology & Nephrology

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

Nicolas Mottet et al.

Summary: The 2020 EAU-EANM-ESTRO-ESUR-SIOG guidelines on screening, diagnosis, and treatment of localized prostate cancer summarize the most recent recommendations for clinical practice, including risk-adapted strategies, medical imaging utilization, biopsy techniques, patient classification, and treatment options. Recommendations include consideration of moderate hypofractionation for intermediate-risk patients and a combination of local treatment with long-term hormonal therapy for cN1 PCa patients.

EUROPEAN UROLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Factors Affecting Pathologic Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer: Development and Validation of a Predictive Nomogram

Soo-Yeon Kim et al.

Summary: A nomogram incorporating MRI and clinical-pathologic variables was developed to predict pathologic complete response after neoadjuvant chemotherapy in breast cancer. The nomogram showed good discrimination and calibration abilities, effectively identifying independent variables associated with pCR.

RADIOLOGY (2021)

Article Public, Environmental & Occupational Health

Marital status and prostate cancer incidence: a pooled analysis of 12 case-control studies from the PRACTICAL consortium

Charlotte Salmon et al.

Summary: Being widowed is associated with a higher risk of incident prostate cancer, particularly with tumors that have spread beyond the prostate. Single men also have an elevated risk of high-grade cancers. Social support interventions and closer medical follow-up are recommended for these populations.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2021)

Article Oncology

Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study

Andrei Gafita et al.

Summary: Nomograms developed in this study can predict outcomes after Lu-177-PSMA in patients with mCRPC. These predictive models can assist in guiding clinical trial design and individual clinical decision-making, especially in institutions where Lu-177-PSMA is introduced as a novel therapeutic option.

LANCET ONCOLOGY (2021)

Article Medical Informatics

Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the Surveillance, Epidemiology, and End Results (SEER) database

Changhee Lee et al.

Summary: The study compared different prognostic models and found that the machine learning-based Survival Quilts model had good discrimination for predicting 10-year prostate cancer-specific mortality, similar to the top multivariable models. Additionally, it was found that multivariable models outperformed tier-based models when models were stratified.

LANCET DIGITAL HEALTH (2021)

Article Oncology

An independently validated survival nomogram for lower-grade glioma

Haley Gittleman et al.

NEURO-ONCOLOGY (2020)

Review Urology & Nephrology

Harnessing the potential of multimodal radiotherapy in prostate cancer

Yiannis Philippou et al.

NATURE REVIEWS UROLOGY (2020)

Review Urology & Nephrology

Prostate cancer screening and treatment: where have we come from and where are we going?

Peter C. Albertsen

BJU INTERNATIONAL (2020)

Article Public, Environmental & Occupational Health

Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity — United States, 2001–2017

David A. Siegel et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Article Oncology

Cancer treatment and survivorship statistics, 2019

Kimberly D. Miller et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2019)

Editorial Material Urology & Nephrology

TNM clinical staging of prostate cancer: issues and solutions

Murali Varma et al.

BJU INTERNATIONAL (2019)

Review Medicine, General & Internal

Screening for Prostate Cancer US Preventive Services Task Force Recommendation Statement

David C. Grossman et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

Article Medicine, General & Internal

Radical Prostatectomy or Watchful Waiting in Prostate Cancer-29-Year Follow-up

Anna Bill-Axelson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Urology & Nephrology

Men presenting with prostate-specific antigen (PSA) values of over 100 ng/mL

Mann Ang et al.

BJU INTERNATIONAL (2016)

Article Urology & Nephrology

A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score

Jonathan I. Epstein et al.

EUROPEAN UROLOGY (2016)

Article Medicine, General & Internal

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

F. C. Hamdy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Medicine, General & Internal

Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study

Vincent J. Gnanapragasam et al.

PLOS MEDICINE (2016)

Review Oncology

PSA Screening for Prostate Cancer: Why Saying No is a High-Value Health Care Choice

Timothy J. Wilt et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2015)

Review Oncology

Chemotherapy in Prostate Cancer

Michael Hurwitz

CURRENT ONCOLOGY REPORTS (2015)

Editorial Material Urology & Nephrology

KIDNEY CANCER A new nomogram predicting survival in renal cell carcinoma

Borje Ljungberg

NATURE REVIEWS UROLOGY (2010)

Article Oncology

How to build and interpret a nomogram for cancer prognosis

Alexia Iasonos et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

Article Urology & Nephrology

Prostate specific antigen density correlates with features of prostate cancer aggressiveness

Shilajit D. Kundu et al.

JOURNAL OF UROLOGY (2007)

Article Medicine, General & Internal

Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter

IM Thompson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Review Oncology

Prostate cancer in black and white Americans

S Reddy et al.

CANCER AND METASTASIS REVIEWS (2003)